Administration-Time Differences in Effects of Hypertension Medications on Ambulatory Blood Pressure Regulation

REFERENCES

• Acelajado MC, Pisoni R, Dudenbostel T, Oparil S, Calhoun DA, Glasser SP. (2012). Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. J. Am. Soc. Hypertens. 6:66–72.
   PubMed Web of Science ®Google Scholar
• Almirall J, Comas L, Martínez-Ocaña JC, Roca S, Arnau A. (2012). Effects of chronotherapy on blood pressure control in non-dipper patients with refractory hypertension. Nephrol. Dial. Transplant. 27:1855–1859.
   PubMed Web of Science ®Google Scholar
• Angeli A, Gatti G, Masera R. (1992). Chronobiology of the hypothalamic-pituitary-adrenal and renin-angiotensin-aldosterone systems. In Touitou Y, Haus E (Eds.). Biologic rhythms in clinical and laboratory medicine. Berlin: Springer Verlag, 292–314.
   Google Scholar
• Arangino S, Cagnacci A, Angiolucci M, Vacca AMB, Longu G, Volpe A, Melis G. (1999). Effect of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am. J. Cardiol. 83:1417–1419.
   PubMed Web of Science ®Google Scholar
• Arendt J. (1997). The pineal gland, circadian rhythms and photoperiodism. In Redfern PH, Lemmer B (Eds.). Physiology and pharmacology of biological rhythms. Berlin: Springer Verlag, 375–414.
   Google Scholar
• Arendt J, Skene DJ, Middelton B, Lockley SW, Deacon S. (1997). Efficacy of melatonin treatment in jet lag, shift work and blindness. J Biol. Rhythms 12:604–617.
   PubMed Web of Science ®Google Scholar
• Ashizawa N, Seto S, Shibata Y, Yano K. (2007). Bedtime administration of cilnidipine controls morning hypertension. Int. Heart J. 48:597–603.
   PubMed Web of Science ®Google Scholar
• Asmar R, Gosse P, Queré S, Achouba A. (2011). Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood Press. Monit. 16:80–86.
   PubMed Web of Science ®Google Scholar
• Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J. Hypertens. 25:2479–2485.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC. (2010). Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 27:345–362.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Portaluppi F, Smolensky MH, on behalf of the Hygia Project Investigators. (2011). Bedtime hypertension treatment increases ambulatory blood pressure control and reduces cardiovascular risk in resistant hypertension. Hypertension 58:e26.
   PubMed Web of Science ®Google Scholar
• Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30: 340–352.
   Web of Science ®Google Scholar
• Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol. Int. 30: 99–115.
   Web of Science ®Google Scholar
• Ayala DE, Ucieda R, Hermida RC. (2013c). Chronotherapy with low-dose aspirin for prevention of complications in pregrancy. Chronobiol. Int. 30: 260–279.
   Google Scholar
• Balan H, Popescu E, Angelescu G. (2011). Comparing different treatment schedules of Zomen (zofenopril). Rom. J. Intern. Med. 49:75–84.
   PubMedGoogle Scholar
• Bartter FC, Chan JCM, Simpson HW. (1979). Chronobiological aspect of plasma renin activity, plasma aldosterone and urinary electrolytes. In Krieger DT (Ed.). Endocrine rhythms. New York: Raven Press, 49–132.
   Google Scholar
• Bélanger PM, Bruguerolle B, Labrecque G. (1997). Rhythms in pharmacokinetics: absorption, distribution, metabolism. In Redfern PH, Lemmer B (Eds.). Physiology and pharmacology of biological rhythms. Handbook of experimental pharmacology series, Vol. 125. Berlin, New York: Springer Verlag, 177–204.
   Google Scholar
• Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241.
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH , Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group. (2003). Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 289:2073–2082.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219–1229.
   PubMed Web of Science ®Google Scholar
• Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560–567.
   PubMed Web of Science ®Google Scholar
• Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92–97.
   PubMed Web of Science ®Google Scholar
• Bruguerolle B, Lemmer B. (1993). Recent advances in chronopharmacokinetics: methodological problems. Life Sci. 52:1809–1824.
   PubMed Web of Science ®Google Scholar
• Cabezas-Cerrato J, Hermida RC, Cabezas-Agrícola JM, Ayala DE. (2009). Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus. Chronobiol. Int. 26:942–957.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB. (1998). Influences of melatonin administration on the circulation of women. Am. J. Physiol. 274:R335–R338.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Angiolucci M, Melis GB, Facchinetti F, Malmusi S, Volpe A. (2001). Effect of exogenous melatonin on vascular reactivity and nitric oxide in post menopausal women: role of hormone replacement therapy. Clin. Endocrinol. 54:26–266.
   Web of Science ®Google Scholar
• Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. (2005). Prolonged melatonin administration decreases nocturnal blood pressure in women. Am. J. Hypertens. 18:1614–1618.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. (2008). Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:1403–1419.
   PubMed Web of Science ®Google Scholar
• Casetta I, Granieri E, Portaluppi F, Manfredini R. (2002). Circadian variability in hemorrhagic stroke. JAMA 287:1266–1267.
   PubMed Web of Science ®Google Scholar
• Cavallo A, Daniels SR, Dolan LM, Bean JA, Khoury JC. (2004). Blood pressure-lowering effect of melatonin in type 1 diabetes. J. Pineal Res. 36:262–266.
   PubMed Web of Science ®Google Scholar
• Chasen C, Muller JE. (1998). Cardiovascular triggers and morning events. Blood Press. Monit. 3:35–42.
   PubMedGoogle Scholar
• Chau NP, Bauduceau B, Chanudet X, Larroque P, Gautier D. (1994). Ambulatory blood pressure in diabetic subjects. Am. J. Hypertens. 7:487–491.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Cohen MC, Rohtla KM, Lavery CE, Muller JE, Middleman MA. (1997). Meta analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol. 79:1512–1516.
   PubMed Web of Science ®Google Scholar
• Cornélissen G, Halberg F, Prikryl P, Dankova E, Siegelova J, Dusek J, International Womb-To-Tomb Chronome Study Group. (1991). Prophylactic aspirin treatment: the merits of timing. JAMA 266:3128–3129.
   PubMed Web of Science ®Google Scholar
• Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329–340.
   PubMed Web of Science ®Google Scholar
• Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30: 43–54.
   Web of Science ®Google Scholar
• Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol. Int. 30: 159–175.
   Web of Science ®Google Scholar
• Cugini P. (1996). The treatability of refractory or resistant hypertension by personalized antihypertensive chronotherapy based on ambulatory monitoring of the arterial pressure. Recenti Prog. Med. 87:51–57
   PubMedGoogle Scholar
• Cugini P. (1997). Compliance and the chronotherapy of refractory arterial hypertension. Recenti Prog. Med. 88:463–469.
   PubMedGoogle Scholar
• Cugini P, Manconi E, Serdoz N, Mancini A, Meucci R, Scavo D. (1980). Rhythm characteristics of plasma renin, aldosterone and cortisol in five types of mesor-hypertension. J. Endocrinol. Invest. 3:143–149.
   PubMed Web of Science ®Google Scholar
• Cugini P, Letizia C, Scavo D. (1988). The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with the circadian cycle of plasma renin and aldosterone. Chronobiologia 15:229–232.
   PubMedGoogle Scholar
• Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. (2001). High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J. Hypertens. 19:2063–2070.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C, Magnaghi G, Maisaidi M, Zanchetti A. (2006). Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J. Hypertens. 24:647–653.
   PubMed Web of Science ®Google Scholar
• Dahlöf B. (2009). Management of cardiovascular risk with RAS inhibitor/CCB combination therapy. J. Hum. Hypertens. 23:77–85.
   PubMed Web of Science ®Google Scholar
• Deedwania PC (Ed.). (1997). Circadian rhythms of cardiovascular disorders. Armonk, NY: Futura Publishing.
   Google Scholar
• Deedwania PC, Nelson J. (1990). Pathophysiology of silent ischemia during daily life. Circulation. 82:1296–1304.
   PubMed Web of Science ®Google Scholar
• Defina LF, Bookstaver DA, Goldfinger MP, Coffey TA. (1997). Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring. Ann. Pharmacother. 31:819–822.
   PubMed Web of Science ®Google Scholar
• de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E, Pallarés V, Sarría A, Aranda P, Ruilope LM, for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. (2009). Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 53:466–472.
   PubMed Web of Science ®Google Scholar
• de Leeuw PW, Falke HE, Kho TL, Vandongen R, Wester A, Birkenhäger H (1977). Effects of beta-agrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta Med. Scand. 202:389–392.
   PubMedGoogle Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161.
   PubMed Web of Science ®Google Scholar
• Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479–1513.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am. J. Hypertens. 21:443–450.
   PubMed Web of Science ®Google Scholar
• Ekmekcioglu C, Thalhammer T, Mehrabi M, Glogar H, Holzenbein T, Markovic O, Leibetseder VJ, Strauss-Blasche G, Marktl W. (2003). The melatonin receptor subtype MT2 is present in the human cardiovascular system. J. Pineal Res. 35:40–44.
   PubMed Web of Science ®Google Scholar
• Elliot WJ. (1998). Circadian variation in the timing of stroke onset. A meta-analysis. Stroke 29:992–996.
   PubMed Web of Science ®Google Scholar
• Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. (1996). Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am. J. Hypertens. 9:1139–1143.
   PubMed Web of Science ®Google Scholar
• Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus BR. (2006). Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352–358.
   PubMed Web of Science ®Google Scholar
• Fagard RH. (2012). Resistant hypertension. Heart 98:254–161.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61.
   PubMed Web of Science ®Google Scholar
• Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036–2045.
   PubMed Web of Science ®Google Scholar
• Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. (1993a). Evening vs. morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br. J. Clin. Pharmacol. 35:51–54.
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. (1993b). Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am. J. Hypertens. 6:1–7.
   PubMed Web of Science ®Google Scholar
• Fujimura A, Ebihara A, Shiigai T, Shimada K, Tagawa H, Gomi T, Nakamura Y, Suzuki M, Yokozuka H. (1999). Amelioration of enalapril-induced dry cough by changing dosing time from morning to evening: a preliminary trial. Jpn. J. Clin. Pharmacol. Ther. 30:741–744.
   Google Scholar
• Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, Cerutti S, Lombardi F, Pagani M, Malliani A. (1990). Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 81:537–547.
   PubMed Web of Science ®Google Scholar
• Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
   PubMed Web of Science ®Google Scholar
• Giles TD. (2003). Rationale for combination therapy as initial treatment for hypertension. J. Clin. Hypertens. 5(4 Suppl 3):4–11.
   Google Scholar
• Gordon RD, Wolfe LK, Island DP, Liddle GW. (1966). A diurnal rhythm in plasma renin activity in man. J. Clin. Invest. 45:1587–1592.
   PubMed Web of Science ®Google Scholar
• Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. (1994). Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin. Invest. 72:864–869.
   PubMedGoogle Scholar
• Grosser N, Schroder H. (2003). Aspirin protects endothelial cells from oxidant damage via the nitric-oxide-cGMP pathway. Arterioscler. Thromb. Vasc. Biol. 23:1345–1351.
   PubMed Web of Science ®Google Scholar
• Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. (2006). Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am. J. Med. 119:898–902.
   PubMed Web of Science ®Google Scholar
• Grossman E, Laudon M, Zisapel N. (2011). Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc. Health Risk Manag. 7:577–584.
   PubMedGoogle Scholar
• Grundy JS, Foster RT. (1996). The nifedipine gastrointestinal and therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. J. Clin. Pharmacokinet. 30:28–51.
   Web of Science ®Google Scholar
• Gupta SK, Yih BM, Atkinson L, Longstreth J. (1995). The effect of food, time of dosing and body composition on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil. J. Clin. Pharmacol. 35:1083–1093.
   PubMed Web of Science ®Google Scholar
• Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749–775.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension 54:40–46.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501–505.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, Fernández JR. (1997). Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 30:589–595.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesias M. (1999). Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 34:1016–1023.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097–1104.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. (2003a). Administration-time dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension 41:1259–1267.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Iglesias M. (2003b). Administration-time dependent influence of aspirin on blood pressure in pregnant women. Hypertension 41:651–656.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Mojón A, López JE. (2003c). Administration-time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 42:283–290.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004). Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277–296.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C. (2005a). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453–459
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE. (2005b). Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients. J. Am. Coll. Cardiol. 46:975–983.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, López JE. (2005c). Treatment of non-dipper hypertension with bedtime administration of valsartan. J. Hypertens. 23:1913–1922.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, López JE. (2005d). Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 46:960–968.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Fontao MJ, Soler R, Fernández JR. (2005e). Effects of the time of day of antihypertensive treatment on the ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 46:1053–1059.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Covelo M. (2005f). Administration time-dependent effects of amlodipine on ambulatory blood pressure in patients with essential hypertension. Am. J. Hypertens. 18(5 Pt 2):61A.
   Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Mojón A, Rodríguez M, Chayán L, López JE, Fontao MJ, Soler R, Fernández JR. (2005g). Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol. Int. 22:755–776.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Rodríguez M, Chayán L, López JE. (2006). Administration time-dependent effects of nebivolol on the diurnal/nocturnal blood pressure ratio in hypertensive patients. J. Hypertens. 24( Suppl 4):S89.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Calvo C. (2007a). Optimal timing of antihypertensive dosing: focus on valsartan. Ther. Clin. Risk Manag. 3:119–131.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007b). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923–939.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007c). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715–722.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Portaluppi F. (2007d). Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904–922.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, Lopez JE, Rodriguez M, Chayan L, Mojon A, Fontao MJ. Fernandez JR. (2007e). Dose- and administration-time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 24:471–493.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2008a). Comparison of the efficacy of morning versus bedtime administration of 40 mg/day olmesartan in essential hypertension. 23rd Annual Scientific Meeting and Exposition of the American Society of Hypertension New Orleans (Louisiana, USA), May 14–17, 2008. J. Clin. Hypertens. 10( Suppl A):A22.
   Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008b). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69–76.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Chayán L, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. (2008c). Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol. Int. 25:950–970.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2008d). Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am. J. Hypertens. 21:948–954.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009a). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61–79.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojon A, Alonso I, Fernandez JR. (2009b). Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Press. Monit. 14:152–159.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2009c). Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am. J. Hypertens. 22:896–903.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. (2010a). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol. Int. 27:560–574.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2010b). Chronotherapy with valsartan/amlodipine combination in essential hypertension: improved blood pressure control with bedtime dosing. Chronobiol. Int. 27:1287–1303.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010c). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010d). Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am. J. Hypertens. 23:432–439.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR. (2011e). Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol. Int. 28:601–610.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012a). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012b). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297–305.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. (2013a). Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol. Int. 30: 176–191.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30: 68–86.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013c). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol. Int. 30: 87–98.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013d). Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30: 328–339.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30: 315–327.
   Web of Science ®Google Scholar
• Hermida RC, Ríos MT, Crespo JJ, Moya A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE, on behalf on the Hygia Project Investigators. (2013f). Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension. Chronobiol. Int. 30: 192–206.
   Web of Science ®Google Scholar
• Hoshino A, Nakamura T, Matsubara H. (2010). The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin. Exp. Hypertens. 32:416–422.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Matsubara T, Sato Y, Sakamoto N. (1993). Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J. Hypertens. 11:581–587.
   PubMed Web of Science ®Google Scholar
• Inaba M, Noguchi Y, Yamamoto T, Imai T, Hatano M, Yagi S, Katayama S. (2004). Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens. Res. 27:141–145.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295:2859–2866.
   PubMed Web of Science ®Google Scholar
• Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. (2003). Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press. 12:19–24.
   PubMed Web of Science ®Google Scholar
• Jumabay M, Ozawa Y, Kawamura H, Saito S, Izumi Y, Mitsubayashi H, Kawasaki Y, Nakayama T, Mahumut M, Cheng Z, Wang S, Kammatsuse K. (2002). Ambulatory blood pressure monitoring in Uygur centenarians. Circ. J. 66:75–79.
   PubMed Web of Science ®Google Scholar
• Kanabrocki EL, George M, Hermida RC, Messmore HL, Ryan MD, Ayala DE, Hoppensteadt DA, Fareed J, Bremmer FW, Third JLHC, Shirazi P, Nemchausky BA. (2001). Day-night variations in blood levels of nitric oxide, T-TFPI and E-selectin. Clin. Appl. Thromb. Hemost. 7:339–345.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Sasaki Y, Aizaka R, Shimisu T. (2001). The effects of oral melatonin on the automatic function in healthy subjects. Psychiatry Clin. Neurosci. 55:299–300.
   PubMed Web of Science ®Google Scholar
• Kanzik I, Cakici I, Ersoy S, Ark M, Abacioglu N, Zengil H. (1992). Effects of cyclooxygenase and lipoxygenase inhibitors on digoxin-induced arrhythmias and haemodynamics in guinea-pigs. Pharmacol. Res. 26:305–316.
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. (2001). Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38:852–857.
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107:1401–1406.
   PubMed Web of Science ®Google Scholar
• Katz F, Romfh P, Smith JA. (1975). Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J. Clin. Endocrinol. Metab. 40:125–134.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Tochikubo O, Minamisawa K, Miyajima E, Ishii M. (1994). Circadian variation of hemodynamics in patients with essential hypertension: comparison between early morning and evening. J. Hypertens. 12:1405–1412.
   PubMed Web of Science ®Google Scholar
• Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishino H, Koike H. (1987). Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin. Exp. Hypertens. A9:1121–1131.
   Google Scholar
• Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240–245.
   PubMed Web of Science ®Google Scholar
• Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, Hino T, Otsuka Y, Kushiro T, Kanmatsuse K. (2004). Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J. Cardiovasc. Pharmacol. 43:68–73.
   PubMed Web of Science ®Google Scholar
• Koga H, Hayashi J, Yamamoto M, Kitamoto K. (2005). Prevention of morning surge of hypertension by the evening administration of carvedilol. Jap. Med. Assoc. J. 48:398–403.
   Google Scholar
• Kohno I, Iwasaki H, Okutani M, Mochizuki Y, Sano S, Satoh Y, Ishihara T, Ishii H, Mukaiyama S, Ijiri H, Komori S, Tamura K. (1997). Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients. Chronobiol. Int. 14:71–84.
   PubMed Web of Science ®Google Scholar
• Kohno I, Ijiri H, Takusagawa M, Yin DF, Sano S, Ishihara T, Sawanobori T, Komori S, Tamura K. (2000). Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration. Chronobiol. Int. 17:209–219.
   PubMed Web of Science ®Google Scholar
• Koopman MG, Koomen GC, Krediet RT, de Moor EA, Hoek FJ, Arisz L. (1989). Circadian rhythm of glomerular filtration rate in normal individuals. Clin. Sci. (Lond.) 77:105–111.
   PubMed Web of Science ®Google Scholar
• Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, Mito H, Shimada K. (2004). Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens. Res. 27:15–20.
   PubMed Web of Science ®Google Scholar
• Laflamme A, Wu L, Foucart S, de Chamlain J. (1998). Impaired basal sympathetic tone and alpha 1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am. J. Hypertens. 11:219–229.
   PubMed Web of Science ®Google Scholar
• Lakatua DJ, Haus E, Halberg F, Halberg E, Wendt HW, Sackett-Lundeen LL, Berg HG, Kawasaki T, Ueno M, Uezono K, Matsuoka M, Omae T. (1986). Circadian characteristics of urinary epinephrine and norepinephrine from healthy young women in Japan and U.S.A. Chronobiol. Int. 3:189–195.
   PubMed Web of Science ®Google Scholar
• Labrecque G, Beauchamp D. (2003). Rhythms and pharmacokinetics. In Redfern P (Ed.). Chronotherapeutics. London: Pharmaceutical Press, 75–110.
   Google Scholar
• Langner B, Lemmer B. (1988). Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur. J. Clin. Pharmacol. 33:619–624.
   PubMed Web of Science ®Google Scholar
• Lasko BH, Laplante A, Hebert D, Bonnefis-Boyer S. (2001). Canadian valsartan study in patients with mild-to-moderate hypertension. Blood Press. Monit. 6:91–99.
   PubMed Web of Science ®Google Scholar
• Leenen FHH. (1996). Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines. Am. J. Hypertens. 9:97S–104S.
   Google Scholar
• Lemmer B. (1999). Chronopharmacokinetics—implications for drug treatment. J. Pharm. Pharmacol. 51:887–890.
   PubMed Web of Science ®Google Scholar
• Lemmer B. (2000). Cardiovascular chronobiology and chronopharmacology. Importance of timing of dosing. In White WB (Ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, 255–271.
   Google Scholar
• Lemmer B, Nold G. (2003). Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to atage 2 primary hypertension. Blood Press. Monit. 8:119–125.
   PubMed Web of Science ®Google Scholar
• Lemmer B, Portaluppi F. (1997). Chronopharmacology of cardiovascular diseases. In Redfern P, Lemmer B (Eds.). Physiology and pharmacology of biological rhythms. Handbook of experimental pharmacology, Vol. 125. Heidelberg, Germany: Springer Verlag, 251–297.
   Google Scholar
• Lemmer B, Nold G, Behne S, Kaiser R. (1991). Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int. 8:485–494.
   PubMed Web of Science ®Google Scholar
• Liebson PR. (2006). Calcium channel blockers in the spectrum of antihypertensive agents. Exp. Opin. Pharmacother. 7:2385–2401.
   PubMed Web of Science ®Google Scholar
• Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. (1985). Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 60:1210–1215.
   PubMed Web of Science ®Google Scholar
• Lusardi P, Preti P, Savino S, Piazza E, Zoppi A, Fogari R. (1997). Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press Monit. 2:99–103.
   PubMedGoogle Scholar
• Lusardi P, Piazza E, Fogari R. (2000). Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br. J. Clin. Pharmacol. 49:423–427.
   PubMed Web of Science ®Google Scholar
• Macchiarulo C, Pieri R, Mitolo DC, Pirrelli A. (1999). Management of antihypertensive treatment with lisinopril: a chronotherapeutic approach. Eur. Rev. Med. Pharmacol. Sci. 3:269–275.
   PubMedGoogle Scholar
• Mancia G, Omboni S, Parati G, on behalf of the investigators of the INSIGHT ABPM substudy. (2002). Twenty-four hours ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J. Hypertens. 20:545–553.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865–868.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Gallerani M, Portaluppi F, Salmi R, Fersini C. (1997). Chronobiological patterns of onset of acute cerebrovascular diseases. Thromb. Res. 88:451–463.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Portaluppi F. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives [letter]. Circulation 108:e72–e73.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555–559.
   PubMed Web of Science ®Google Scholar
• Manfredini R, Boari B, Salmi R, Fabbian F, Pala M, Tiseo R, Portaluppi F. (2013). Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol. Int. 30: 6–16.
   Web of Science ®Google Scholar
• Mehta HR, Manfredini R, Hassan F, Sechtem U, Bossone E, Oh JK, Cooper JV, Smith DE, Portaluppi F, Penn M, Hutchison S, Nienaber CA, Isselbacher EM, Eagle KA. (2002). Chronobiological patterns of acute aortic dissection. Circulation 106:1110–1115.
   PubMed Web of Science ®Google Scholar
• Meilhac B, Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, Dallocchio M. (1992). Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours. Therapie 47:205–210.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang Z, Liang X, Wu C, Qi G. (2010). Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension. Acta Cardiol. 65:309–314.
   PubMed Web of Science ®Google Scholar
• Mengden T, Binswanger B, Spühler T, Weisser B, Vetter W. (1993). The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J. Hypertens. 11:1403–1411.
   PubMed Web of Science ®Google Scholar
• Middeke M, Kluglich M, Holzgreve H. (1991). Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing. Chronobiol. Int. 8:506–510.
   PubMed Web of Science ®Google Scholar
• Milani RV. (2005). Reaching for aggressive blood pressure goals: role of angiotensin receptor blockade in combination therapy. Am. J. Manag. Care 11( Suppl 7):S220–S227.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L. (2007). Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am. J. Kidney Dis. 50:908–917.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch. Intern. Med. 171:1090–1098.
   PubMed Web of Science ®Google Scholar
• Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol. Int. 30: 145–158.
   Web of Science ®Google Scholar
• Morgan TO. (2009). Does it matter when drugs are taken? Hypertension 54:23–24.
   PubMed Web of Science ®Google Scholar
• Morgan T, Anderson A, Jones E. (1997). The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J. Hypertens. 15:205–211.
   PubMed Web of Science ®Google Scholar
• Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, on behalf on the Hygia Project Investigators. (2013). Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Chronobiol. Int. 30: 116–131.
   Web of Science ®Google Scholar
• Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. (2003). Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press. Monit. 8:181–185.
   PubMedGoogle Scholar
• Myburgh DP, Verho M, Botes JH, Erasmus ThP, Luus HG. (1995). 24-Hour pressure control with ramipril: comparison of once-daily morning and evening administration. Curr. Ther. Res. 56:1298–1306.
   Web of Science ®Google Scholar
• Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes 47:1501–1506.
   PubMed Web of Science ®Google Scholar
• Neutel JM, Smith DHG. (2003). Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J. Clin. Hypertens. 1:58–63.
   Google Scholar
• Neutel J, Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M. (1997). Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin. Ther. 19:447–458.
   PubMed Web of Science ®Google Scholar
• Niegowska J, Niegowska M, Jasinski B. (2005). Telmisartan in monotherapy of essential hypertension in young men—time of drug administration and 24-hours blood pressure and heart rate. Pol. Arch. Med. Wewn. 114:868–873.
   PubMedGoogle Scholar
• Nold G, Strobel G, Lemmer B. (1998). Morning vs evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press. Monit. 3:17–25.
   PubMedGoogle Scholar
• O'Brien E, Sheridan J, O'Malley K. (1988). Dippers and non-dippers [letter]. Lancet 13:397.
   Google Scholar
• Ocón J, Mora J. (1990). Twenty-four-hour blood pressure monitoring and effects of indapamide. Am. J. Cardiol. 65:p58H–61H.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Ohmori M, Fujimura A. ACE inhibitors and chronotherapy. (2005). Clin. Exp. Hypertens. 2–3:179–185
   Google Scholar
• Okyar A, Dressler C, Hanafy A, Baktir G, Lemmer B, Spahn-Langguth H. (2012). Circadian variations in exsorptive transport: in-situ intestinal perfusion data and in-vivo relevance. Chronobiol. Int. 29:443–453.
   PubMed Web of Science ®Google Scholar
• O'Sullivan C, Duggan J, Atkins N, ÓBrien E. (2003). Twenty-four-hour ambulatory blood pressure in community-dwelling elderly men and women aged 60–102 years. J. Hypertens. 21:1641–1647.
   PubMed Web of Science ®Google Scholar
• Palatini P. (1992). Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours? Am. Heart J. 123:1421–1425.
   PubMed Web of Science ®Google Scholar
• Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. (1992). Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin. Pharmacol. Ther. 52:378–383.
   PubMed Web of Science ®Google Scholar
• Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, Pavan E, Pessina AC. (1993). Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int. J. Clin. Pharmacol. Ther. Toxicol. 31:295–300.
   PubMed Web of Science ®Google Scholar
• Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, Weinstock RS, Shea S. (2008). Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J. Clin. Hypertens. (Greenwich) 10:12–20.
   PubMed Web of Science ®Google Scholar
• Panza JA, Epstein SE, Quyyumi AA. (1991). Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N. Engl. J. Med. 325:986–990.
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G. (2010). Evening administration of antihypertensive drugs: filling a knowledge gap. J. Hypertens. 28:1390–1392.
   PubMed Web of Science ®Google Scholar
• Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, Dave G, Forni L. (1985). Clinical pharmacology of platelet cyclo-oxygenase inhibition. Circulation 72:1177–1184.
   PubMed Web of Science ®Google Scholar
• Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M. (1998). Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J. Hypertens. 16:385–393.
   PubMed Web of Science ®Google Scholar
• Petrie K, Dawson AG, Thompson L, Brook R. (1993). A double blind trial of melatonin as a treatment for jet-lag in international cabin crew. Biol. Psychiatry 33:526–530.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Levenstein M, Walmsley P, for the Hypertension and Lipid Trial Study Group. (1994). Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT study. Am. J. Hypertens. 7:844–847.
   PubMed Web of Science ®Google Scholar
• Pistrosch F, Reissmann E, Wildbrett J, Koehler C, Hanefeld M. (2007). Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am. J. Hypertens. 20:541–545.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940–951.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH. (2000). Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In White WB (Ed.). Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, pp.79–118.
   Google Scholar
• Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia. J. Clin. Endocrinol. Metab. 78:1075–1078.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. (1995). Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens. 8:719–726.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Manfredini R, Fersini C. (1999). From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events. Chronobiol. Int. 16:33–49.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
   PubMed Web of Science ®Google Scholar
• Qiu YG, Chen JZ, Zhu JH, Yao XY. (2003). Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc. Drugs Ther. 17:335–341.
   PubMed Web of Science ®Google Scholar
• Qiu YG, Zhu JH, Tao QM, Zheng P, Chen JZ, Hu SJ, Zhang FR, Zheng LR, Zhao LL, Yao XY. (2005). Captopril administered at night restores the diurnal blood pressure rhythm in adequately controlled, nondipping hypertensives. Cardiovasc. Drugs Ther. 19:189–195.
   PubMed Web of Science ®Google Scholar
• Raftery EB, Melville DI, Gould BA, Mann S, Whittington JR. (1981). A study of the antihypertensive action of xipadime using ambulatory intra-arterial monitoring. Br. J. Clin. Pharmacol. 12:381–385.
   PubMed Web of Science ®Google Scholar
• Ray CA. (2003). Melatonin attenuates sympathetic nerve response to orthostatic stress in humans. J. Physiol. 551:1043–1048.
   PubMed Web of Science ®Google Scholar
• Rechcinski T, Kurpesa M, Trzos E, Krzeminska-Pakula M. (2006). The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease—preliminary report. Pol. Arch. Med. Wewn. 115:520–528.
   PubMedGoogle Scholar
• Rechcinski T, Trzos E, Wierzbowska-Drabik K, Krzeminska-Pakula M, Kurpesa M. (2010). Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens. Res. 33:56–61.
   PubMed Web of Science ®Google Scholar
• Reinberg A, Smolensky MH. (1982). Circadian changes of drug disposition in man. Clin. Pharmacokinet. 7:401–420.
   PubMed Web of Science ®Google Scholar
• Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol. Int. 30: 207–220.
   Web of Science ®Google Scholar
• Rutter MK, McComb JM, Forster J, Brady S, Marshall SM. (2000). Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet. Med. 17:321–325.
   PubMed Web of Science ®Google Scholar
• Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch. Intern. Med. 168:2340–2346.
   PubMed Web of Science ®Google Scholar
• Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM. (2004). Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43:192–197.
   PubMed Web of Science ®Google Scholar
• Seki S, Taniguchi M, Ohsawa S, Koga A, Ito T, Kunoh M, Imamoto S, Miyazaki H, Takeda S, Iwano K, Satoh C, Kanae K, Mochizuki S. (2005). Chronobiological analysis by ambulatory blood pressure monitoring of the hyperbaric and hypobaric indexes for evaluation of the antihypertensive effect of long-acting nifedipine. Circ. J. 69:1249–1255.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Jarvis B, Goa KL. (2001). Telmisartan: a review of its use in hypertension. Drugs 61:1501–1529.
   PubMed Web of Science ®Google Scholar
• Skene DJ, Lockley SW, Arendt J. (1999). Use of melatonin in the treatment of phase shift and sleep disorders. Adv. Exp. Med. Biol. 467:79–84.
   PubMed Web of Science ®Google Scholar
• Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. (2003). Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J. Hypertens. 21:1291–1298.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Haus E. (2001). Circadian rhythms in clinical medicine with applications to hypertension. Am. J. Hypertens. 14(9 Pt 2):280S–290S.
   PubMedGoogle Scholar
• Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14–S24.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida R, Portaluppi F, Haus E, Reinberg A. (2005). Chronotherapeutics in the treatment of hypertersion. In Oparil S, Weber MA (Eds.). Hypertension: a companion to Brenner and Rector's The Kidney. 2nd ed. Philadelphia: Elsevier Saunders, pp.530–542.
   Google Scholar
• Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007a). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. (2007b). Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol. Int. 24:171–181.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (Eds.). Fundamentals and applications of controlled release drug delivery. Heidelberg: Springer Verlag, pp.359–443.
   Google Scholar
• Snoep JD, Hovens MMC, Pasha SM, Frölich M, Pijl H, Tamsma JT, Huisman MV. (2009). Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension 54:1136–1142.
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Mark AL, Abboud FM. (1993). Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med. 328:303–307.
   PubMed Web of Science ®Google Scholar
• Sothern RB, Vesely DL, Kanabrocki EL, Hermida RC, Bremner FW, Third JLHC, Boles MA, Nemchausky BM, Olwin JH, Scheving LE. (1995). Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 12:106–120.
   PubMed Web of Science ®Google Scholar
• Sowers JR, Vlachakis N. (1984). Circadian variation in plasma dopamine levels in man. J. Endocrinol. Invest. 7:341–345.
   PubMed Web of Science ®Google Scholar
• Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, Menzinger G. (2001). Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J. Hum. Hypertens. 15:239–246.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, ÓBrien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350:757–764.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijs L, Fagard R, ÓBrien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators. (1999). Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 282:539–546.
   PubMed Web of Science ®Google Scholar
• Stanton A, O'Brien E. (1994). Auswirkungen der Therapie auf das zirkadiane Blutdruckprofil. Kar-dio 3:1–8.
   Google Scholar
• Sturrock NDC, George E, Pound N, Stevenson J, Peck GM, Sowter H. (2000). Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet. Med. 17:360–364.
   PubMed Web of Science ®Google Scholar
• Sunaga K, Fujimura A, Shiga T, Ebihara A. (1995). Chronopharmacology of enalapril in hypertensive patients. Eur. J. Clin. Pharmacol. 48:441–445.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Aizawa Y. (2011). Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes. Clin. Exp. Hypertens. 33:56–62.
   PubMed Web of Science ®Google Scholar
• Svensson P, de Faire U, Sleight P, Yusuf S, Östergren J. (2001). Comparative effects of ramipril on ambulatory and office blood pressures. A HOPE substudy. Hypertension 38:e28–e32.
   PubMed Web of Science ®Google Scholar
• Taubert D, Berkels R, Grosser N, Schroder H, Grundemann D, Schomig E. (2004). Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br. J. Pharmacol. 143:159–165.
   PubMed Web of Science ®Google Scholar
• Tofé S, García B. (2009). 24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J. Clin. Hypertens. (Greenwhich) 11:426–431.
   PubMed Web of Science ®Google Scholar
• Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, Sato T. (1994). Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension 23( Suppl 1):I211–I214.
   PubMed Web of Science ®Google Scholar
• Uzu T, Kimura G. (1999). Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 100:1635–1638.
   PubMed Web of Science ®Google Scholar
• Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. (1997). Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 96:1859–1862.
   PubMed Web of Science ®Google Scholar
• van de Borne P, Nguyen H, Biston P, Linkowski P, Degaute JP. (1994). Effects of wake and sleep stages on the 24-h autonomic control of blood pressure and heart rate in recumbent men. Am. J. Physiol. 266(2 Pt 2):H548–H554.
   PubMedGoogle Scholar
• Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999a). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
   PubMed Web of Science ®Google Scholar
• Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999b). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499–2502.
   PubMed Web of Science ®Google Scholar
• Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285–289.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801.
   PubMed Web of Science ®Google Scholar
• Weekley LB. (1993). Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin. Auton. Res. 3:45–47.
   PubMedGoogle Scholar
• White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R. (1999). Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens. 12:806–814.
   PubMed Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Vesely DL. (1988). Circadian rhythm of prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126 in man. Chronobiol. Int. 5:403–409.
   PubMed Web of Science ®Google Scholar
• Witte K, Lemmer B. (2003). Rhythms and pharmacodynamics. In Redfern P (ed.). Chronotherapeutics. London: Pharmaceutical Press, pp.111–126.
   Google Scholar
• Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, Lemmer B. (1993). Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin. Pharmacol. Ther. 54:177–186.
   PubMed Web of Science ®Google Scholar
• Wu R, Lamontagne D, de Champlain J. (2002). Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105:387–392.
   PubMed Web of Science ®Google Scholar
• Wu R, Laplante MA, de Champlain J. (2004). Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J. Hypertens. 22:793–801.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342:145–153.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Bianchi L, Bozza M, and the Italian Nifedipine GITS Study Group. (1994). Antihypertensive effects of nifedipine GITS on clinic and ambulatory blood pressures in essential hypertensives. High Blood Pressure 3:45–56.
   Google Scholar
• Zaslavskaia RM, Narmanova OZ, Teiblium MM, Kalimurzina BS. (1999). Time-dependent effects of ramipril in patients with hypertension of 2 stage. Klin. Mad. (Mosk.) 77:41–44.
   PubMedGoogle Scholar
• Zaslavskaia RM, Komarov FI, Makarova LA, Shakirova AN, Narmanova OZh, Biiasilov N. (2000). Time-dependent effects of antihypertensive agents and chronocorrecting action of melatonin in patients with arterial hypertension. Vestn. Ross. Akad. Med. Nauk. 8:36–41.
   Google Scholar
• Zaslavskaia RM, Lilitsa GV, Dilmagambetova GS, Halberg F, Cornélissen G, Otsuka K, Singh R B, Stoynev A, Ikonomov O, Tarquini R, Perfetto F, Schwartzkopff O, Bakken EE. (2004). Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering. Biomed. Pharmacotherapy 58:S129–S134.
   PubMed Web of Science ®Google Scholar
• Zaslavskaia RM, Shcherban' EA, Logvinenko SI. (2008). Melatonin in combined therapy of patients with stable angina and arterial hypertension. Klin. Med. (Mosk.) 86:64–67.
   PubMedGoogle Scholar
• Zeman M, Dulková K, Bada V, Herichová I. (2005). Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci. 76:1795–1803.
   PubMed Web of Science ®Google Scholar
• Zeng J, Jia M, Ran H, Zhang Y, Zhang J, Wang X, Wang H, Yang C, Zeng C. (2011). Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing—a multicenter, open-label randomized study. Hypertens. Res. 34:767–772.
   PubMed Web of Science ®Google Scholar